WHO ICTRP trial
Effect of vitamin D supplementation on pegylated interferon/ribavirin/simeprevir…
JPRN-UMIN000012666 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000012666 |
|---|---|
| Public title | Effect of vitamin D supplementation on pegylated interferon/ribavirin/simeprevir therapy for chronic hepatitis C genotype 1b: Pilot Study |
| Scientific title | Effect of vitamin D supplementation on pegylated interferon/ribavirin/simeprevir therapy for chronic hepatitis C genotype 1b: Pilot Study - Triple therapy + vitamin D |
| Primary sponsor | Hiroshima liver study group |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Japan |
| Conditions | Chronic hepatitis C |
| Interventions | peginterferon alfa-2b, ribavirin and simeprevir plus vitamin D(prior to triple therapy) peginterferon alfa-2b, ribavirin and simeprevir plus vitamin D(concurrent with triple therapy) peginterferon alfa-2b, ribavirin and simeprevir plus… |
| Registration date | Dec 24, 2013 |
| Target size | 30 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: